A molecular result rather than an imaging guess

A fictional adult has a frontal lesion with a histological pattern that suggests a diffuse glioma. The laboratory separately confirms an IDH mutation and whole-arm codeletion of 1p and 19q. A trainee wants to explain the diagnosis as proven by the enhancing image alone and then guarantee the same treatment response for every person with the label. The multidisciplinary supervisor separates morphology, defining molecular evidence and prognostic information. The exercise supplies the molecular results explicitly and does not infer them from a scan. It contains no medicine dose, radiation schedule or individualized operative instruction. The clinical discussion must still account for grade, function, tumor extent, patient factors and the relevant contemporary treatment framework.